Filing Details
- Accession Number:
- 0001144204-18-013456
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-07 21:47:06
- Reporting Period:
- 2018-03-05
- Accepted Time:
- 2018-03-07 21:47:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1069899 | Phibro Animal Health Corp | PAHC | Pharmaceutical Preparations (2834) | 131840497 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1601576 | M Daniel Bendheim | 300 Frank W. Burr Blvd. Ste 21 Teaneck NJ 07666 | Exec. Vp, Corporate Strategy | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2018-03-05 | 3,860 | $11.83 | 3,860 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2018-03-05 | 3,860 | $40.06 | 0 | No | 4 | S | Direct | |
| Class A Common Stock | Acquisiton | 2018-03-06 | 100 | $11.83 | 100 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2018-03-06 | 100 | $40.15 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Option to purchase Common Stock | Disposition | 2018-03-05 | 3,860 | $0.00 | 3,860 | $11.83 |
| Class A Common Stock | Option to purchase Common Stock | Disposition | 2018-03-06 | 100 | $0.00 | 100 | $11.83 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 23,263 | 2012-03-01 | 2019-02-28 | No | 4 | M | Direct |
| 23,163 | 2012-03-01 | 2019-02-28 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.15, inclusive.
Billionaire Hedge Funds
